Correlation Between Royal Canadian and Pfizer

Can any of the company-specific risk be diversified away by investing in both Royal Canadian and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royal Canadian and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Royal Canadian Mint and Pfizer Inc CDR, you can compare the effects of market volatilities on Royal Canadian and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royal Canadian with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royal Canadian and Pfizer.

Diversification Opportunities for Royal Canadian and Pfizer

-0.36

Correlation Coefficient

Royal Canadian  Pfizer

Very good diversification

The 3 months correlation between Royal and Pfizer is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Royal Canadian Mint and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Royal Canadian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royal Canadian Mint are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Royal Canadian i.e., Royal Canadian and Pfizer go up and down completely randomly.

Pair Corralation between Royal Canadian and Pfizer

Assuming the 90 days trading horizon Royal Canadian Mint is expected to generate 0.8 times more return on investment than Pfizer. However, Royal Canadian Mint is 1.25 times less risky than Pfizer. It trades about 0.15 of its potential returns per unit of risk. Pfizer Inc CDR is currently generating about -0.07 per unit of risk. If you would invest  3,457  in Royal Canadian Mint on September 3, 2024 and sell it today you would earn a total of  365.00  from holding Royal Canadian Mint or generate 10.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Royal Canadian Mint  vs.  Pfizer Inc CDR

Royal Canadian Mint

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Royal Canadian Mint are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Royal Canadian may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pfizer Inc CDR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Pfizer is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Royal Canadian and Pfizer

The main advantage of trading using opposite Royal Canadian and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royal Canadian position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.

The idea behind Royal Canadian Mint and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.